>

GlaxoSmithKline Stock Profile

<div class='circular--portrait' style='background:#FF6600;color: white;font-size:6em;padding-top: 0px;;'>G</div>

Performance

0 / 100

Odds of Distress

Equity ratings for GlaxoSmithKline PLC are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.

GlaxoSmithKline PLC Profile

Next fiscal quarter end is expected on March 31, 2020. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline PLC operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange. more on GlaxoSmithKline PLC
GlaxoSmithKline PLC Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
GlaxoSmithKline PLC SEC Filings
GlaxoSmithKline PLC SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameGlaxoSmithKline PLC
CEOEmma WalmsleyView All
Thematic Classification
Currently Active Investing Idea
  Drugs
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering GlaxoSmithKline PLC
Piotroski F Score
Academic score to determine the current strength of GlaxoSmithKline PLC financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
GlaxoSmithKline PLC ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: A+Very Firm
Profitability
Few selected profitability drivers of GlaxoSmithKline PLC representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
GlaxoSmithKline PLC (GSK) is traded on BATS Exchange in USA. It is located in 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom and employs 95,490 people. GlaxoSmithKline PLC is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 117.89 B. GlaxoSmithKline PLC runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 2.49 B outstanding shares of which 6.65 M shares are currently shorted by investors with about 2.88 days to cover shorted positions. GLAXOSMITHKLINE P has about 5.12 B in cash with (5.78 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08.
Check GlaxoSmithKline PLC Probability Of Bankruptcy

Ownership Allocation (%)

GlaxoSmithKline Stock Price Odds Analysis

Odds Below 41.69HorizonTargetOdds Above 41.69
0.25%30 days 41.69 99.75%
Based on normal probability distribution, the odds of GlaxoSmithKline PLC to move above current price in 30 days from now is close to 99 (This GlaxoSmithKline PLC probability density function shows the probability of GlaxoSmithKline PLC Stock to fall within a particular range of prices over 30 days) .

GlaxoSmithKline Stock Top Holders

GlaxoSmithKline PLC Income Statement Over Time

GlaxoSmithKline Stock Against Markets

Did you try this?

Run Portfolio Reporting Now

   

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
All  Next Launch Module

GlaxoSmithKline PLC Upcoming and Recent Events

GlaxoSmithKline PLC Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMay 6, 2020
Next Earnings ReportJuly 22, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 3, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

GlaxoSmithKline PLC Corporate Filings

GlaxoSmithKline PLC SEC Reporting

Unclassified Corporate Event

GlaxoSmithKline PLC Distributions to stockholders

GlaxoSmithKline PLC Corporate Directors

Vindi Banga Senior Independent Non-Executive Director
Lynn Elsenhans Independent Non-Executive Director
Daniel Podolsky Non-Executive Independent Director
Please check Risk vs Return Analysis. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Company logos by clearbit